tradingkey.logo
tradingkey.logo
Search

Rapport Therapeutics Inc

RAPP
Add to Watchlist
40.980USD
-1.800-4.21%
Close 07-31 16:00ETQuotes delayed by 15 min
1.96BMarket Cap
LossP/E TTM

RAPP Financials

See Rapport Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Rapport Therapeutics Inc Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-0.42/-0.67
Revenue / Forecast
20.00M/8.57M
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.86
24.17%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
Financial Indicators
EPS
38.39%-0.42
-26.29%-0.72
-41.08%-0.71
-52.23%-0.75
-6.48%-0.68
-33.51%-0.57
-111.31%-0.50
-173.39%-0.50
-268.78%-0.64
---0.43
---0.24
---0.18
---0.17
----
Revenue
--20.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
Net Profit
17.48%-19.86M
-68.98%-33.76M
-53.53%-26.93M
-47.52%-26.73M
-6.15%-24.06M
-47.79%-19.98M
-101.37%-17.54M
-182.65%-18.12M
-268.78%-22.67M
---13.52M
---8.71M
---6.41M
---6.15M
----
Net Margin
---99.28%
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
--100.00%
----
----
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
--0.00%
----
--0.00%
--0.00%
----
----
----
----
----
Revenue
--20.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
10.67%-24.21M
-63.72%-38.51M
-38.57%-29.99M
-41.81%-29.50M
-58.58%-27.11M
-58.99%-23.52M
-126.27%-21.64M
-213.73%-20.80M
-229.30%-17.09M
---14.79M
---9.56M
---6.63M
---5.19M
----
Net Profit
17.48%-19.86M
-68.98%-33.76M
-53.53%-26.93M
-47.52%-26.73M
-6.15%-24.06M
-47.79%-19.98M
-101.37%-17.54M
-182.65%-18.12M
-268.78%-22.67M
---13.52M
---8.71M
---6.41M
---6.15M
----
Current assets
66.58%484.69M
60.93%498.56M
59.74%520.66M
-20.67%270.24M
46.42%290.97M
--309.80M
--325.94M
--340.67M
--198.73M
----
----
----
----
----
Total current liabilities
90.74%17.90M
117.28%19.05M
101.66%14.32M
46.74%11.88M
-5.08%9.38M
--8.77M
--7.10M
--8.10M
--9.88M
----
----
----
----
----
Total assets
64.74%497.60M
62.71%512.43M
61.66%535.32M
-17.51%285.50M
46.42%302.05M
--314.93M
--331.14M
--346.10M
--206.29M
----
----
----
----
----
Total liabilities
60.85%26.09M
192.22%27.78M
195.22%23.71M
138.63%21.98M
45.01%16.22M
--9.51M
--8.03M
--9.21M
--11.18M
----
----
----
----
----
Total equity
64.96%471.51M
58.68%484.65M
58.34%511.62M
-21.78%263.51M
46.50%285.84M
--305.43M
--323.11M
--336.89M
--195.11M
----
----
----
----
----
Net operating income
35.46%-13.06M
-70.99%-24.70M
-6.40%-17.46M
-53.31%-25.07M
-14.89%-20.24M
-39.48%-14.45M
-202.64%-16.41M
-147.80%-16.35M
-266.90%-17.61M
---10.36M
---5.42M
---6.60M
---4.80M
----
Net investment
80.41%37.94M
-645.96%-174.32M
-7.04%-56.78M
121.10%22.60M
150.16%21.03M
140.59%31.93M
-101901.92%-53.04M
-124439.53%-107.10M
-68631.15%-41.93M
---78.66M
---52.00K
---86.00K
---61.00K
----
Net financing
10520.00%531.00K
4342.86%311.00K
19506.96%270.53M
-100.04%-63.00K
-99.99%5.00K
105.00%7.00K
-101.63%-1.39M
177158.89%159.35M
6.09%63.66M
---140.00K
--85.36M
---90.00K
--60.01M
----

FAQs

What are the current assets of Rapport Therapeutics Inc?

According to Rapport Therapeutics Inc's FY2025 earnings report, its current assets were 498.56M, with a year-on-year change of 60.93.

What are the total assets of Rapport Therapeutics Inc?

According to Rapport Therapeutics Inc's FY2025 earnings report, its total assets of Rapport Therapeutics Inc were 512.43M, with a year-on-year change of 62.71.

What are the total liabilities of Rapport Therapeutics Inc?

According to Rapport Therapeutics Inc's FY2025 earnings report, its total liabilities of Rapport Therapeutics Inc were 27.78M, with a year-on-year change of 192.22.

What is the total equity of Rapport Therapeutics Inc?

According to Rapport Therapeutics Inc's FY2025 earnings report, its total equity of Rapport Therapeutics Inc was 484.65M, with a year-on-year change of 58.68.

What is the net operating income of Rapport Therapeutics Inc?

According to Rapport Therapeutics Inc's FY2025 earnings report, its net operating income of Rapport Therapeutics Inc was -125.10M, with a year-on-year change of -50.62.

What is the net investment of Rapport Therapeutics Inc?

According to Rapport Therapeutics Inc's FY2025 earnings report, its net investment of Rapport Therapeutics Inc was -187.47M, with a year-on-year change of -10.19.

What is the net financing of Rapport Therapeutics Inc?

According to Rapport Therapeutics Inc's FY2025 earnings report, its net financing of Rapport Therapeutics Inc was 270.79M, with a year-on-year change of 22.18.

What is the Earnings Per Share (EPS) of Rapport Therapeutics Inc?

According to Rapport Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.86, with a year-on-year change of 24.17.

What is the net income of Rapport Therapeutics Inc?

According to Rapport Therapeutics Inc's FY2025 earnings report, its net income was -111.48M, with a year-on-year change of -42.37.

What is the Return on Equity (ROE) of Rapport Therapeutics Inc?

According to Rapport Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -28.22, with a year-on-year change of 49.58.

What is the Return on Assets (ROA) of Rapport Therapeutics Inc?

According to Rapport Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -26.95, with a year-on-year change of 19.06.

What is the operating profit of Rapport Therapeutics Inc?

According to Rapport Therapeutics Inc's FY2025 earnings report, its operating profit was -125.10M, with a year-on-year change of -50.62.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.